Biosimilars: Global Access & Reimbursement - 2018 Report - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Nov 27, 2018--The “Biosimilars: Global Access & Reimbursement” report from Decision Resources Group has been added to ResearchAndMarkets.com’s offering.
Global Biosimilars Access & Reimbursement, provides brand-level insight regarding the impact of payer policy on physician prescribing behavior in the Global Biosimilars market so you can optimize your market access strategy and determine how to best position your biosimilar to specific stakeholders.
This report includes specific detail on the Biosimilars market access trends globally, insight on how to maximize opportunity and limit barriers, analysis of key reimbursement decision-makers and the criteria they use, review of market access strategies used by competitors and highlights of where they succeeded or stumbled, detailed analysis of physician and payer perceptions based on physician surveys in-depth interviews with payers, and much more.
This report is most relevant for professionals in market research, business intelligence, market access, brand teams, launch planning teams, business development & licensing. This report was published in December 2017.
Key Topics Covered
1. Access & Reimbursement Landscape 1.1 Key Findings 1.2 EU 1.3 United States 1.4 Japan 1.5 Australia 1.6 Brazil 1.7 Canada 1.8 China 1.9 India 1.10 Mexico 1.11 Russia 1.12 South Korea
For more information about this report visit https://www.researchandmarkets.com/research/l348n2/biosimilars?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20181127005556/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Biosimilars and Biosuperiors
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL OTHER HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 11/27/2018 09:50 AM/DISC: 11/27/2018 09:50 AM